LYTIR

Company · HELP

Helus Pharma Inc.

Nasdaq's symbol directory lists HELP on Nasdaq as “Helus Pharma Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 8 occasions ($8.4M); 4 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $8.4M in total; Insider sales: $0 in total.Aug: Insider purchases $1.0MSep: Insider purchases $7.4MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $8.4MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Eric H. L. So, Executive Chair bought on 3 days latest Sep 8, 2026 bought $3.6M
  2. Paul Glavine, Chief Growth Officer bought on 3 days latest Sep 8, 2026 bought $3.5M
  3. Michael Halstead, Chief Executive Officer bought on 1 day latest Sep 21, 2026 bought $1.3M
  4. Greg Cavers, Chief Financial Officer bought on 1 day latest Sep 29, 2026 bought $39K
Every trade (8)
  1. BUYGreg Cavers, Chief Financial Officer bought Sep 29, 2026 3,000 shares filing $39K
  2. BUYMichael Halstead, Chief Executive Officer bought Sep 21, 2026 100,000 shares filing $1.3M
  3. BUYPaul Glavine, Chief Growth Officer bought Sep 8, 2026 100,000 shares filing $1.2M
  4. BUYEric H. L. So, Executive Chair bought Sep 8, 2026 100,000 shares filing $1.2M
  5. BUYEric H. L. So, Executive Chair bought Sep 4, 2026 100,000 shares filing $1.2M
  6. BUYPaul Glavine, Chief Growth Officer bought Sep 3, 2026 100,000 shares filing $1.2M
  7. BUYEric H. L. So, Executive Chair bought Sep 1, 2026 95,000 shares filing $1.1M
  8. BUYPaul Glavine, Chief Growth Officer bought Aug 31, 2026 90,000 shares filing $1.0M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. So Eric H. L. filed Sep 9, 2026 Schedule 13D may seek influence 4,423,894 shares issuer: Cybin Inc. filing 5.8%
  2. Glavine Paul filed Sep 9, 2026 Schedule 13D may seek influence 4,407,456 shares issuer: Cybin Inc. filing 5.8%
  3. Sirenia Capital Management LP filed Aug 14, 2026 Schedule 13G/A passive issuer: CYBIN INC. filing 4.8%
  4. Adage Capital Management, L.P. filed Aug 12, 2026 Schedule 13G passive issuer: Cybin Inc. filing 5.29%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.